225 related articles for article (PubMed ID: 29846953)
1. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study.
Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Marques MEA; Miot HA
Int J Cosmet Sci; 2018 Aug; 40(4):420-424. PubMed ID: 29846953
[TBL] [Abstract][Full Text] [Related]
2. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.
Tamega Ade A; Miot HA; Moço NP; Silva MG; Marques ME; Miot LD
Int J Cosmet Sci; 2015 Apr; 37(2):222-8. PubMed ID: 25439299
[TBL] [Abstract][Full Text] [Related]
3. Role of fibroblast-derived factors in the pathogenesis of melasma.
Byun JW; Park IS; Choi GS; Shin J
Clin Exp Dermatol; 2016 Aug; 41(6):601-9. PubMed ID: 27416970
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.
Alcantara GP; Esposito ACC; Olivatti TOF; Yoshida MM; Miot HA
An Bras Dermatol; 2020; 95(6):684-690. PubMed ID: 33010989
[TBL] [Abstract][Full Text] [Related]
5. Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma.
Kim JY; Lee TR; Lee AY
J Invest Dermatol; 2013 Jan; 133(1):191-200. PubMed ID: 22951732
[TBL] [Abstract][Full Text] [Related]
6. Changes in nuclear morphology and chromatin texture of basal keratinocytes in melasma.
Brianezi G; Handel AC; Schmitt JV; Miot LD; Miot HA
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):809-12. PubMed ID: 24629163
[TBL] [Abstract][Full Text] [Related]
7. Melasma: histopathological characteristics in 56 Korean patients.
Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma.
Kang HY; Suzuki I; Lee DJ; Ha J; Reiniche P; Aubert J; Deret S; Zugaj D; Voegel JJ; Ortonne JP
J Invest Dermatol; 2011 Aug; 131(8):1692-700. PubMed ID: 21562572
[TBL] [Abstract][Full Text] [Related]
9. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.
Grimes PE; Yamada N; Bhawan J
Am J Dermatopathol; 2005 Apr; 27(2):96-101. PubMed ID: 15798432
[TBL] [Abstract][Full Text] [Related]
10. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
[TBL] [Abstract][Full Text] [Related]
11. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
Attwa E; Khater M; Assaf M; Haleem MA
Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
[TBL] [Abstract][Full Text] [Related]
12. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
[TBL] [Abstract][Full Text] [Related]
13. CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.
Rodríguez-Arámbula A; Torres-Álvarez B; Cortés-García D; Fuentes-Ahumada C; Castanedo-Cázares JP
Am J Dermatopathol; 2015 Oct; 37(10):761-6. PubMed ID: 26381025
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast morphology, growth rate and gene expression in facial melasma.
Espósito ACC; Brianezi G; Miot LDB; Miot HA
An Bras Dermatol; 2022; 97(5):575-582. PubMed ID: 35840442
[TBL] [Abstract][Full Text] [Related]
15. Adaptability of melanocytes post ultraviolet stimulation in patients with melasma.
Wang YJ; Chang CC; Wu YH; Huang L; Shen JW; Lu ME; Chiang HM; Lin BS
Lasers Surg Med; 2023 Sep; 55(7):680-689. PubMed ID: 37365922
[TBL] [Abstract][Full Text] [Related]
16. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.
Bak H; Lee HJ; Chang SE; Choi JH; Kim MN; Kim BJ
Dermatol Surg; 2009 Aug; 35(8):1244-50. PubMed ID: 19438666
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis.
Jang YH; Lee JY; Kang HY; Lee ES; Kim YC
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1312-6. PubMed ID: 20337826
[TBL] [Abstract][Full Text] [Related]
19. Histological classification of melasma with reflectance confocal microscopy: a pilot study in Chinese patients.
Liu H; Lin Y; Nie X; Chen S; Chen X; Shi B; Tian H; Shi Z; Yu M; Zhang D; Yang B; Wang G; Wu M; Zhang F
Skin Res Technol; 2011 Nov; 17(4):398-403. PubMed ID: 21332810
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathology of melasma].
Miot LD; Miot HA; Silva MG; Marques ME
An Bras Dermatol; 2009; 84(6):623-35. PubMed ID: 20191174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
